Streetbeat News

Analyst Ratings

DAVA

Endava (NYSE:DAVA) has received 6 analyst ratings in the last quarter, with 1 being bullish and 5 somewhat bullish. The average price target is $71.0, indicating an upside from the current price of $52.79. The average has increased by 1.43% from the previous target of $70.00.

Portfolio Pulse from Benzinga Insights

September 14, 2023 | 4:00 pm

UNM

Jefferies analyst Daniel Bergman maintains a 'Buy' rating on Unum Gr (NYSE:UNM) and raises the price target from $55 to $59.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 3:58 pm

VRT

Deutsche Bank analyst Nicole Deblase has maintained a 'Buy' rating on Vertiv Holdings (NYSE:VRT) and raised the price target from $39 to $49.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 3:57 pm

FSLR

First Solar's stock has been upgraded from Market Perform to Outperform by BMO Capital, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 3:56 pm

UNH

Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on UnitedHealth Group (NYSE:UNH) and maintained a price target of $591.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 3:56 pm

PRI

Jefferies analyst Suneet Kamath maintains a 'Hold' rating on Primerica (NYSE:PRI) and lowers the price target from $198 to $197.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 3:55 pm

PFG

Jefferies analyst Suneet Kamath maintains a 'Hold' rating on Principal Financial Group (NASDAQ:PFG) and lowers the price target from $69 to $66.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 3:55 pm

UHS

Cantor Fitzgerald analyst Sarah James has reiterated an Underweight rating on Universal Health Services (NYSE:UHS) and maintained a price target of $148.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 3:53 pm

RGA

Jefferies analyst Suneet Kamath maintains a 'Hold' rating on Reinsurance Gr (NYSE:RGA) and lowers the price target from $160 to $159.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 3:53 pm

SGRY

Cantor Fitzgerald analyst Sarah James has reiterated her Overweight rating on Surgery Partners (NASDAQ:SGRY) and maintained a price target of $43.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 3:52 pm